ArticleBreast cancer research and treatment2024

Palbociclib sensitizes ER-positive breast cancer cells to fulvestrant by promoting the ubiquitin-mediated degradation of ER-α via SNHG17/Hippo-YAP axis.

Lei Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.